☆ 4.7 Article

Antibody-platinum (IV) prodrugs conjugates for targeted treatment of cutaneous squamous cell carcinoma

Journal of Pharmaceutical Analysis (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Chemistry, Multidisciplinary

Piezo-Augmented Sonosensitizer with Strong Ultrasound-Propelling Ability for Efficient Treatment of Osteomyelitis

Xiaobo Feng et al.

Summary: The successful treatment of osteomyelitis remains a challenge in the field of orthopedics. Researchers have developed a piezoelectric-enhanced sonosensitizer that effectively eliminates bone infection and suppresses inflammation and bone loss.

ACS NANO (2022)

添加到收藏夹

Review Chemistry, Inorganic & Nuclear

Pt(iv) antitumor prodrugs: dogmas, paradigms, and realities

Mauro Ravera et al.

Summary: Platinum(ii)-based drugs are commonly used for solid tumor treatment, but their clinical use is limited by severe side effects and resistance. To overcome these limitations, Pt(iv) derivatives acting as anticancer prodrugs have been designed, synthesized, and preclinically tested. Although not yet approved for clinical use, these prodrugs show promising pharmacological profiles.

DALTON TRANSACTIONS (2022)

添加到收藏夹

Review Chemistry, Multidisciplinary

Biomedical polymers: synthesis, properties, and applications

Wei-Hai Chen et al.

Summary: This review summarizes the recent advances in the synthesis and application of biomedical polymers, discussing their property-function relationship for corresponding biomedical applications. It highlights emerging bioactive polymers as potential biomaterials for cancer precision therapy. The challenges and outlook for the development of more efficient, healthier, and safer biomedical polymers are also discussed.

SCIENCE CHINA-CHEMISTRY (2022)

添加到收藏夹

Article Chemistry, Physical

Near-Infrared-II Light Induced Mild Hyperthermia Activate Cisplatin-Artemisinin Nanoparticle for Enhanced Chemo/Chemodynamic Therapy and Immunotherapy

Guoliang Xiong et al.

Summary: In this study, a highly efficient metal-free chemodynamic therapy (CDT) was developed using endoperoxide bridge-containing artesunate as the free radical-generating substance. A Pt(IV) prodrug containing two artesunate molecules was synthesized to decompose into cisplatin and artesunate in tumor cells. To improve the catalytic efficiency, a near-infrared-II (NIR-II) photothermal agent was incorporated. The formulated nanomedicine showed accelerated Fenton reaction and induced immunogenic cell death, reversing the immunosuppressive tumor microenvironment and enhancing antitumor immunity.

SMALL METHODS (2022)

添加到收藏夹

Article Biochemistry & Molecular Biology

Long Non-coding RNA Expression Profile in Broiler Liver with Cadmium-Induced Oxidative Damage

Chunlin Yu et al.

Summary: The study found that cadmium exposure induces oxidative damage in broiler liver, leading to changes in lncRNA expression patterns associated with oxidative stress. The enriched GO and KEGG pathways are related to oxidative stress caused by cadmium exposure.

BIOLOGICAL TRACE ELEMENT RESEARCH (2021)

添加到收藏夹

Review Biochemistry & Molecular Biology

An Insight into FDA Approved Antibody-Drug Conjugates for Cancer Therapy

Juliana T. W. Tong et al.

Summary: The emergence of a large number of antibody-drug conjugates (ADCs) for cancer therapy has attracted significant attention globally, with 11 ADCs granted FDA approval as of September 2021, 8 of which have been approved since 2017. Despite challenges, optimism for this therapeutic approach remains high, as evidenced by a landmark year for deals and partnerships in the ADC arena in 2020.

MOLECULES (2021)

添加到收藏夹

Review Oncology

Unlocking the potential of antibody-drug conjugates for cancer therapy

Joshua Z. Drago et al.

Summary: Nine ADCs are currently approved for cancer treatment, with many more in development. Advances in synthetic biochemistry have led to a new generation of ADCs promising improved tissue specificity and cytotoxicity. Despite impressive activity against treatment-refractory cancers, challenges such as systemic toxicity and acquired resistance remain. This review discusses the design, mechanism of action, and limitations of ADCs, proposing strategies to maximize their therapeutic benefit for cancer patients.

NATURE REVIEWS CLINICAL ONCOLOGY (2021)

添加到收藏夹

Article Medicine, Research & Experimental

Augmented antibody-based anticancer therapeutics boost neutrophil cytotoxicity

Niels Heemskerk et al.

Summary: The study created TrisomAb molecules that combined the agonistic activity of IgG mAbs and Fc?RI targeting in a therapeutic bispecific antibody format, recruiting multiple effector cells including NK cells, macrophages, and neutrophils for effective eradication of tumor cells. TrisomAb also showed long in vivo half-life and significantly decreased tumor outgrowth in mice, offering potential alternatives for cancer patients who do not benefit from current IgG mAb therapy.

JOURNAL OF CLINICAL INVESTIGATION (2021)

添加到收藏夹

Article Chemistry, Physical

Enhanced Chemodynamic Therapy and Chemotherapy via Delivery of a Dual Threat ArtePt and Iodo-Click Reaction Mediated Glutathione Consumption

Qiao Jin et al.

Summary: The hybrid artemisinin platinum NP(ArtePt), combining chemodynamic therapy (CDT) with chemotherapy, effectively enhances the therapeutic effects against hepatocellular carcinoma by depleting intracellular GSH via Iodo-Click reaction.

SMALL METHODS (2021)

添加到收藏夹

Article Chemistry, Multidisciplinary

Polyethylene glycol-based linkers as hydrophilicity reservoir for antibody-drug conjugates

T. Tedeschini et al.

Summary: ADCs are a promising therapeutic entity, with research focusing on exploring novel linker-drug architectures to improve their efficacy and stability. Studies have shown that using linkers containing monodisperse poly(ethylene glycol) moieties can enhance the stability and in vivo performance of ADCs.

JOURNAL OF CONTROLLED RELEASE (2021)

添加到收藏夹

Article Chemistry, Multidisciplinary

Site-specific antibody-drug conjugates with variable drug-to-antibody-ratios for AML therapy

Zhefu Dai et al.

Summary: A new technology for producing homogeneous ADCs, ARC-ADCs, was developed by utilizing the human CD38 catalytic domain and its derived inhibitor. Through this technology, ADCs with customizable drug-to-antibody ratios (DARs) can be rapidly generated, showing potent activity in killing hCLL-1-positive AML cells. This work provides novel ADC candidates for combating AML and supports ARC-ADC as a versatile approach for producing site-specific ADCs with defined DARs.

JOURNAL OF CONTROLLED RELEASE (2021)

添加到收藏夹

Article Multidisciplinary Sciences

Antibody-drug conjugates with dual payloads for combating breast tumor heterogeneity and drug resistance

Chisato M. Yamazaki et al.

Summary: In this study, dual-drug ADCs show promising therapeutic potential for treating heterogeneous breast tumors with minimal toxicity and optimal pharmacokinetic profiles. Compared to co-administration of two single-drug variants, the dual-drug ADC exhibits greater treatment effect and survival benefit in xenograft mouse models representing intratumor HER2 heterogeneity and drug resistance.

NATURE COMMUNICATIONS (2021)

添加到收藏夹

Article Multidisciplinary Sciences

Neomenthol prevents the proliferation of skin cancer cells by restraining tubulin polymerization and hyaluronidase activity

Kaneez Fatima et al.

Summary: Neomenthol shows promising antiproliferative activity against skin carcinoma cells by inhibiting tubulin polymerization and hyaluronidase activity, which are responsible for tumor growth, metastasis, and angiogenesis.

JOURNAL OF ADVANCED RESEARCH (2021)

添加到收藏夹

Article Engineering, Biomedical

Nanoparticle-mediated convection-enhanced delivery of a DNA intercalator to gliomas circumvents temozolomide resistance

Yongheng Wang et al.

Summary: Nanoparticles releasing an oxaliplatin prodrug and a cationic DNA intercalator within temozolomide-resistant gliomas inhibit tumor growth without causing detectable toxicity. Combining anticancer drugs with distinct mechanisms of action, selective drug release, and convection-enhanced delivery may represent a translational strategy for the treatment of TMZ-resistant gliomas.

NATURE BIOMEDICAL ENGINEERING (2021)

添加到收藏夹

Article Gastroenterology & Hepatology

In Barrett's epithelial cells, weakly acidic bile salt solutions cause oxidative DNA damage with response and repair mediated by p38

Xiaofang Huo et al.

AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2020)

添加到收藏夹

Article Nanoscience & Nanotechnology

Selective Killing of Shiga Toxin-Producing Escherichia coli with Antibody-Conjugated Chitosan Nanoparticles in the Gastrointestinal Tract

Zhengxin Ma et al.

ACS APPLIED MATERIALS & INTERFACES (2020)

添加到收藏夹

Article Biochemical Research Methods

Rapid, High-Yielding Solid-Phase Synthesis of Cathepsin-B Cleavable Linkers for Targeted Cancer Therapeutics

Alla Pryyma et al.

BIOCONJUGATE CHEMISTRY (2020)

添加到收藏夹

Article Chemistry, Multidisciplinary

Imidazole modified Pt(iv) prodrug-loaded multi-stage pH responsive nanoparticles to overcome cisplatin resistance

Xiaoxu Kang et al.

CHEMICAL COMMUNICATIONS (2020)

添加到收藏夹

Article Chemistry, Multidisciplinary

Clustered nanobody-drug conjugates for targeted cancer therapy

Tiantian Wu et al.

CHEMICAL COMMUNICATIONS (2020)

添加到收藏夹

Review Oncology

Antibody-Drug Conjugate-Based Therapeutics: State of the Science

Michael J. Birrer et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2019)

添加到收藏夹

Review Medicine, General & Internal

Antibody-drug conjugates for cancer

Cindy H. Chau et al.

LANCET (2019)

添加到收藏夹

Article Medicine, General & Internal

Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial

Maura L. Gillison et al.

LANCET (2019)

添加到收藏夹

Article Medicine, Research & Experimental

GSH-sensitive Pt(IV) prodrug-loaded phase-transitional nanoparticles with a hybrid lipid-polymer shell for precise theranostics against ovarian cancer

Hui Huang et al.

THERANOSTICS (2019)

添加到收藏夹

Review Chemistry, Multidisciplinary

Cleavable linkers in antibody-drug conjugates

Jonathan D. Bargh et al.

CHEMICAL SOCIETY REVIEWS (2019)

添加到收藏夹

Review Cell Biology

Antibody-drug conjugates: recent advances in conjugation and linker chemistries

Kyoji Tsuchikama et al.

PROTEIN & CELL (2018)

添加到收藏夹

Article Dermatology

Cutaneous squamous cell carcinoma Incidence, risk factors, diagnosis, and staging

Syril Keena T. Que et al.

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2018)

添加到收藏夹

Article Dermatology

Cutaneous squamous cell carcinoma Management of advanced and high-stage tumors

Syril Keena T. Que et al.

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2018)

添加到收藏夹

Article Chemistry, Multidisciplinary

Glutathione-Scavenging Poly(disulfide amide) Nanoparticles for the Effective Delivery of Pt(IV) Prodrugs and Reversal of Cisplatin Resistance

Xiang Ling et al.

NANO LETTERS (2018)

添加到收藏夹

Article Chemistry, Multidisciplinary

Maximizing Synergistic Activity When Combining RNAi and Platinum-Based Anticancer Agents

Haihua Xiao et al.

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2017)

添加到收藏夹

Review Biotechnology & Applied Microbiology

Strategies and challenges for the next generation of antibody drug conjugates

Alain Beck et al.

NATURE REVIEWS DRUG DISCOVERY (2017)

添加到收藏夹

Article Dermatology

Association of Oncogenic Mutations in Patients With Advanced Cutaneous Squamous Cell Carcinomas Treated With Cetuximab

Alexandra Picard et al.

JAMA DERMATOLOGY (2017)

添加到收藏夹

Article Chemistry, Inorganic & Nuclear

Platinum(IV) anticancer prodrugs - hypotheses and facts

Dan Gibson

DALTON TRANSACTIONS (2016)

添加到收藏夹

Review Oncology

Antibody-drug conjugates for cancer therapy

Anish Thomas et al.

LANCET ONCOLOGY (2016)

添加到收藏夹

Review Biotechnology & Applied Microbiology

Current methods for the synthesis of homogeneous antibody-drug conjugates

Alicja M. Sochaj et al.

BIOTECHNOLOGY ADVANCES (2015)

添加到收藏夹

Article Oncology

Diagnosis and treatment of invasive squamous cell carcinoma of the skin: European consensus-based interdisciplinary guideline

Alexander Stratigos et al.

EUROPEAN JOURNAL OF CANCER (2015)

添加到收藏夹

Review Oncology

The role of DNA repair pathways in cisplatin resistant lung cancer

Shane O'Grady et al.

CANCER TREATMENT REVIEWS (2014)

添加到收藏夹

Review Biochemistry & Molecular Biology

What do we know about the reduction of Pt(IV) pro-drugs?

Ezequiel Wexselblatt et al.

JOURNAL OF INORGANIC BIOCHEMISTRY (2012)

添加到收藏夹

Article Cell Biology

Prognostic Impact of Vitamin B6 Metabolism in Lung Cancer

Lorenzo Galluzzi et al.

CELL REPORTS (2012)

添加到收藏夹

Article Engineering, Biomedical

Biodegradable polymer - cisplatin(IV) conjugate as a pro-drug of cisplatin(II)

Haihua Xiao et al.

BIOMATERIALS (2011)

添加到收藏夹

Review Oncology

Cetuximab in combination therapy: from bench to clinic

David E. Gerber et al.

CANCER AND METASTASIS REVIEWS (2010)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

PET imaging of HER1-expressing xenografts in mice with 86Y-CHX-AaEuro3-DTPA-cetuximab

Tapan K. Nayak et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2010)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.